WASHINGTON - Senators Orin Hatch, R-Utah, and Joseph Lieberman, D-Conn., last week introduced a two-tiered capital gains tax bill that contains measures of explicit benefit to the biotechnology community, particularly venture capital incentives.

The Senate bill will compete with a House-passed bill that does not include the incentives for venture investors.